Posts tagged Aurobindo Pharma
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| 5 Stocks To Buy For 53% Gain In 2018-19 | |
| Company: | Aurobindo Pharma, Axis Bank, Firstsource Solutions Ltd, Muthoot Finance, PVR Ltd |
| Brokerage: | Edelweiss |
| Date of report: | November 13, 2018 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 53% |
| Summary: | Edelweiss Professional Investor Research |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Bank, Edelweiss, Firstsource Solutions Ltd, Muthoot Finance, PVR Ltd |
| Aurobindo Pharma Research Reports + Investors Presentation (Feb 2017) | |
| Company: | Aurobindo Pharma |
| Brokerage: | Axis Direct, Axis Securities, Centrum, ICICI-Direct, IndiaNivesh, Khambatta Securities, Motilal Oswal |
| Date of report: | February 21, 2017 |
| Type of Report: | Investors' Presentation, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 57% |
| Summary: | Strong earnings growth trajectory, improving cash flows to drive valuations |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Securities, Centrum, ICICI-Direct, Indianivesh, Khambatta Securities, Motilal Oswal |
| Aurobindo Pharma Research Report By Motilal Oswal | |
| Company: | Aurobindo Pharma |
| Brokerage: | Motilal Oswal |
| Date of report: | June 28, 2016 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | Verson 2.0 – Bigger, Better, Stronger – Size of a leader + growth of a start-up |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Executive Chairman, Mr Reddy, Mr Sanjeev Dani |